Summary Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type Donepezil Memantine Rivastigmine By Application Early to Moderate Stages Moderate to Severe Stages By Company Merz Pharma Lundbeck. Eisai Daiichi Sankyo Johnson & Johnson Novartis Allergan Pfizer The main contents of the report including: Section 1: Product definition, type and application, global and regional market overview; Section 2: Global and regional Market competition by company; Section 3: Global and regional sales revenue, volume and price by type; Section 4: Global and regional sales revenue, volume and price by application; Section 5: Regional export and import; Section 6: Company information, business overview, sales data and product specifications; Section 7: Industry chain and raw materials; Section 8: SWOT and Porter's Five Forces; Section 9: Conclusion.
Table of Contents 1 Market Overview 1.1 Market Segment Overview 1.1.1 Product Definition 1.1.2 Market by Type 1.1.2.1 Donepezil 1.1.2.2 Memantine 1.1.2.3 Rivastigmine 1.1.3 Market by Application 1.1.3.1 Early to Moderate Stages 1.1.3.2 Moderate to Severe Stages 1.2 Global and Regional Market Size 1.
